Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 11, 2026 11:10 ET | Source: Io Therapeutics, Inc.

Io Therapeutics, Inc. announces publication of studies on the company’s RXR agonist compound IRX4204 for breast cancer prevention

Io Therapeutics reports publication of studies on its RXR agonist compound for prevention of Triple Negative Breast Cancer.
March 10, 2026 14:00 ET | Source: Custom Market Insights

[Latest] Global Pharmaceutical Microbiology QC Testing Market Size/Share Worth USD 17.65 Billion by 2035 at a 13.27% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, SWOT Analysis)

Global Pharmaceutical Microbiology QC Testing Market grows as demand rises for sterility, bioburden, and endotoxin testing in pharmaceutical and biologics.
March 10, 2026 08:03 ET | Source: API Innovation Center

API Innovation Center Highlights Fragility in U.S. Drug Supply Chain in New White Paper

ST. LOUIS, March 10, 2026 (GLOBE NEWSWIRE) -- The API Innovation Center (APIIC), a nonprofit dedicated to strengthening national health security through U.S. generic pharmaceutical manufacturing and...
March 10, 2026 02:30 ET | Source: Custom Market Insights

[Latest] Global Viral Vaccine Cell Culture Media Market Size/Share Worth USD 3.5 Billion by 2035 at a 6.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, March 10, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Viral Vaccine Cell Culture Media Market Size, Trends and Insights By Cell...
March 02, 2026 06:30 ET | Source: Alaunos Therapeutics, Inc.

Alaunos Therapeutics Announces Positive Preclinical Proof-of-Concept Data for ALN1003, a Differentiated Non-Hormonal Oral Treatment for Obesity and Related Metabolic Disorders

Alaunos’ ALN1003 shows dose dependent weight loss, better body composition, reduced liver weight, and improved liver biomarkers in preclinical studies.
February 19, 2026 03:30 ET | Source: Custom Market Insights

Global Amyotrophic Lateral Sclerosis Therapeutics Market Size/Share Worth USD 1964 Million by 2035 at 11.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Global ALS therapeutics market is expected to grow from USD 1.05B in 2025 to USD 1.96B by 2034 at 11.5% CAGR, driven by new therapies and rising worldwide.
February 17, 2026 07:51 ET | Source: BCC Research LLC

Whey Protein Products: Powering Performance and Nutrition Across Global Markets

Demand for Whey Protein Products: Global Markets grow from $9.1 billion in 2025 to $12.9 billion by the end of 2030, at a CAGR of 7.2% from 2025 to 2030.
February 17, 2026 07:05 ET | Source: Lifecore Biomedical, Inc.

Lifecore Biomedical to Participate at DCAT Week 2026

CHASKA, Minn., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”),...
February 12, 2026 07:30 ET | Source: MicrobiotiX

MicrobiotiX and West Africa Centre for Innovative Research and Care Formalize Landmark Phage Therapy Collaboration in Ghana

MicrobiotiX and WAFCIRC sign MoU and Research Collaboration Agreement in Ghana, launching clinical research to evaluate phage therapy for AMR infections.
February 05, 2026 04:53 ET | Source: Exact Therapeutics AS

EXACT Therapeutics: Exercise of Warrants by GE Medical Holding AB

GE Medical Holding AB exercises all its Warrants in EXACT Therapeutics resulting in gross proceeds of NOK 33 million. Reference is made to the stock exchange announcement published on 27 January 2026...